Overview

Biological Basis of Individual Variation in Social Cooperation

Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
The project has three overall objectives. The first is to determine whether and how administration of intranasal oxytocin (OT) and intranasal vasopressin (AVP) influence cooperative decision-making and neural responses to cooperative and un-cooperative social interactions. The second is to determine whether and how intranasal vasopressin influences subjective evaluations of and neural responses to same and opposite-sex face stimuli and to determine if any of these effects persist beyond the period of AVP exposure. The third objective is to determine if intranasal OT influences empathy-related behavior and associated brain activity.
Phase:
N/A
Details
Lead Sponsor:
Emory University
James K. Rilling, PhD
Collaborators:
John Templeton Foundation
National Institute of Mental Health (NIMH)
Treatments:
Arginine Vasopressin
Lorazepam
Oxytocin
Vasopressins